<p>Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports

Published:2020-07 Issue: Volume:Volume 13 Page:6789-6793
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Shi Xuefei^ORCID,Zhou Jia,Qian Caihua,Gao Liliang,Wang Bin,Feng Xueren

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference19 articles.

1. Cancer statistics, 2018

2. Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice

3. Management of non-small cell lung cancer in the era of personalized medicine

4. MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non–small Cell Lung Cancers Expressing Wild-type EGFR Family Members

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects;Liver Research;2023-06

2. Image‐guided thermal ablation for patients with epidermal growth factor receptor‐mutant nonsmall cell lung cancer;Asia-Pacific Journal of Clinical Oncology;2022-12-08

3. Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review;Translational Lung Cancer Research;2021-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP